 Carolyn Welsh
Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchiolitis Obliterans | 2 | 2015 | 71 | 0.730 |
Why?
| | Societies, Medical | 2 | 2015 | 768 | 0.510 |
Why?
| | Lung Diseases | 5 | 2024 | 759 | 0.450 |
Why?
| | Lung Transplantation | 1 | 2015 | 282 | 0.390 |
Why?
| | Pulmonary Medicine | 2 | 2014 | 80 | 0.300 |
Why?
| | Venous Thrombosis | 2 | 2007 | 161 | 0.290 |
Why?
| | Hypercapnia | 1 | 2007 | 56 | 0.290 |
Why?
| | Systems Biology | 1 | 2007 | 59 | 0.270 |
Why?
| | Deoxycytidine | 1 | 2007 | 167 | 0.260 |
Why?
| | Palliative Care | 2 | 2024 | 718 | 0.240 |
Why?
| | Endotoxins | 4 | 1993 | 222 | 0.230 |
Why?
| | Syphilis, Cutaneous | 1 | 2004 | 3 | 0.230 |
Why?
| | Treponema pallidum | 1 | 2004 | 7 | 0.230 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 70 | 0.220 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2007 | 242 | 0.220 |
Why?
| | Pneumonia | 2 | 2007 | 616 | 0.210 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2024 | 150 | 0.190 |
Why?
| | Patient Care Team | 2 | 2024 | 612 | 0.180 |
Why?
| | Physician's Role | 1 | 2003 | 203 | 0.180 |
Why?
| | Patient Compliance | 1 | 2024 | 565 | 0.170 |
Why?
| | Chronic Pain | 1 | 2024 | 251 | 0.170 |
Why?
| | Pentoxifylline | 2 | 1991 | 24 | 0.170 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2024 | 986 | 0.160 |
Why?
| | Brain Injuries, Traumatic | 1 | 2024 | 339 | 0.160 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 1579 | 0.150 |
Why?
| | Heart Failure | 2 | 2024 | 2164 | 0.150 |
Why?
| | Lung Diseases, Interstitial | 2 | 2024 | 606 | 0.140 |
Why?
| | Neutrophils | 4 | 1991 | 1209 | 0.120 |
Why?
| | Prazosin | 1 | 2015 | 27 | 0.120 |
Why?
| | Dreams | 1 | 2015 | 11 | 0.120 |
Why?
| | Telemedicine | 1 | 2024 | 791 | 0.120 |
Why?
| | Capillary Permeability | 4 | 1993 | 141 | 0.120 |
Why?
| | Pneumonia, Mycoplasma | 1 | 1995 | 54 | 0.110 |
Why?
| | Syndrome | 1 | 2015 | 343 | 0.110 |
Why?
| | Veterans | 2 | 2024 | 1428 | 0.110 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2019 | 1381 | 0.110 |
Why?
| | Pulmonary Ventilation | 1 | 1993 | 77 | 0.100 |
Why?
| | Salmonella enteritidis | 2 | 1989 | 18 | 0.100 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2024 | 836 | 0.100 |
Why?
| | Pulmonary Embolism | 3 | 1999 | 211 | 0.100 |
Why?
| | Quality of Life | 2 | 2024 | 2735 | 0.090 |
Why?
| | Acclimatization | 1 | 1993 | 161 | 0.090 |
Why?
| | Sleep Wake Disorders | 1 | 2015 | 251 | 0.090 |
Why?
| | Respiratory Insufficiency | 1 | 1995 | 319 | 0.090 |
Why?
| | Antibiotics, Antitubercular | 1 | 1991 | 37 | 0.090 |
Why?
| | Pulmonary Circulation | 2 | 1993 | 430 | 0.090 |
Why?
| | Humans | 21 | 2024 | 130305 | 0.090 |
Why?
| | Gastrectomy | 1 | 1991 | 99 | 0.080 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1991 | 137 | 0.080 |
Why?
| | Lung | 6 | 1999 | 3967 | 0.080 |
Why?
| | Theobromine | 1 | 1988 | 2 | 0.080 |
Why?
| | Altitude | 1 | 1993 | 451 | 0.080 |
Why?
| | Pulmonary Artery | 2 | 1993 | 1099 | 0.080 |
Why?
| | Aging | 1 | 1998 | 1785 | 0.070 |
Why?
| | Aged | 8 | 2024 | 22282 | 0.070 |
Why?
| | Blood Proteins | 2 | 1993 | 239 | 0.070 |
Why?
| | Male | 14 | 2024 | 63748 | 0.070 |
Why?
| | Diagnosis | 1 | 2007 | 10 | 0.070 |
Why?
| | Mycobacterium tuberculosis | 1 | 1991 | 316 | 0.070 |
Why?
| | Carboplatin | 1 | 2007 | 140 | 0.070 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 1537 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 3 | 2004 | 2551 | 0.070 |
Why?
| | Single-Blind Method | 2 | 2024 | 274 | 0.060 |
Why?
| | Pulmonary Edema | 3 | 1993 | 107 | 0.060 |
Why?
| | Dyspnea | 1 | 2007 | 236 | 0.060 |
Why?
| | Asthma | 2 | 2014 | 2265 | 0.060 |
Why?
| | Risk | 1 | 2007 | 873 | 0.060 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2007 | 227 | 0.060 |
Why?
| | Endothelium, Vascular | 1 | 1991 | 926 | 0.060 |
Why?
| | Middle Aged | 8 | 2024 | 31322 | 0.050 |
Why?
| | Biopsy, Needle | 1 | 2004 | 192 | 0.050 |
Why?
| | Social Workers | 1 | 2024 | 40 | 0.050 |
Why?
| | Comorbidity | 2 | 2024 | 1555 | 0.050 |
Why?
| | Radiography, Thoracic | 1 | 2004 | 164 | 0.050 |
Why?
| | Activated Protein C Resistance | 1 | 2003 | 2 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2015 | 2511 | 0.050 |
Why?
| | Medical Laboratory Science | 1 | 2003 | 9 | 0.050 |
Why?
| | Factor V | 1 | 2003 | 20 | 0.050 |
Why?
| | Information Systems | 1 | 2003 | 63 | 0.050 |
Why?
| | Obesity | 2 | 2007 | 2869 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2007 | 2785 | 0.050 |
Why?
| | Ossification, Heterotopic | 1 | 2002 | 17 | 0.050 |
Why?
| | Adult | 7 | 2024 | 35711 | 0.050 |
Why?
| | Nurse's Role | 1 | 2024 | 140 | 0.050 |
Why?
| | Certification | 1 | 2003 | 95 | 0.050 |
Why?
| | Age Distribution | 1 | 2003 | 379 | 0.050 |
Why?
| | Sex Distribution | 1 | 2003 | 361 | 0.050 |
Why?
| | Patient Readmission | 1 | 2007 | 680 | 0.050 |
Why?
| | Canada | 1 | 2003 | 356 | 0.050 |
Why?
| | Nurses | 1 | 2024 | 164 | 0.050 |
Why?
| | Workload | 1 | 2003 | 154 | 0.050 |
Why?
| | Employment | 1 | 2003 | 166 | 0.050 |
Why?
| | Needs Assessment | 1 | 2003 | 363 | 0.040 |
Why?
| | Terminal Care | 1 | 2024 | 239 | 0.040 |
Why?
| | Hypoxia | 1 | 2007 | 1075 | 0.040 |
Why?
| | Dogs | 3 | 1993 | 377 | 0.040 |
Why?
| | Ambulatory Care | 1 | 2024 | 511 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1711 | 0.040 |
Why?
| | Calcinosis | 1 | 2002 | 258 | 0.040 |
Why?
| | Respiration, Artificial | 1 | 2004 | 600 | 0.040 |
Why?
| | Female | 9 | 2024 | 68842 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2004 | 4961 | 0.040 |
Why?
| | Snoring | 1 | 1998 | 12 | 0.040 |
Why?
| | Respiratory Muscles | 1 | 1998 | 32 | 0.040 |
Why?
| | Lung Diseases, Obstructive | 1 | 1998 | 46 | 0.040 |
Why?
| | Pulmonary Gas Exchange | 1 | 1998 | 119 | 0.040 |
Why?
| | Respiratory Mechanics | 1 | 1998 | 65 | 0.040 |
Why?
| | Carcinoma, Small Cell | 1 | 1998 | 170 | 0.040 |
Why?
| | Sleep Apnea Syndromes | 1 | 1998 | 78 | 0.040 |
Why?
| | Ventilation-Perfusion Ratio | 2 | 1998 | 10 | 0.040 |
Why?
| | United States | 2 | 2024 | 14110 | 0.030 |
Why?
| | Chronic Disease | 2 | 2019 | 1727 | 0.030 |
Why?
| | Advance Care Planning | 1 | 2019 | 206 | 0.030 |
Why?
| | Depression | 1 | 2024 | 1298 | 0.030 |
Why?
| | Tuberculosis | 1 | 1998 | 273 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2003 | 1095 | 0.030 |
Why?
| | Adrenergic alpha-1 Receptor Antagonists | 1 | 2015 | 19 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2003 | 2282 | 0.030 |
Why?
| | Physicians | 1 | 2003 | 865 | 0.030 |
Why?
| | Maximal Midexpiratory Flow Rate | 1 | 1993 | 3 | 0.030 |
Why?
| | Sleep | 1 | 1998 | 673 | 0.030 |
Why?
| | Spirometry | 1 | 1993 | 252 | 0.020 |
Why?
| | Proteins | 2 | 1989 | 948 | 0.020 |
Why?
| | Vital Capacity | 1 | 1993 | 289 | 0.020 |
Why?
| | Time Factors | 2 | 2015 | 6615 | 0.020 |
Why?
| | Forced Expiratory Volume | 1 | 1993 | 509 | 0.020 |
Why?
| | Coronary Vessels | 1 | 1993 | 254 | 0.020 |
Why?
| | Chromium Radioisotopes | 1 | 1991 | 4 | 0.020 |
Why?
| | Drug Resistance, Microbial | 1 | 1991 | 67 | 0.020 |
Why?
| | Permeability | 1 | 1991 | 158 | 0.020 |
Why?
| | Albumins | 1 | 1991 | 103 | 0.020 |
Why?
| | Intestinal Absorption | 1 | 1991 | 98 | 0.020 |
Why?
| | Radiography | 1 | 1993 | 874 | 0.020 |
Why?
| | Vascular Surgical Procedures | 1 | 1993 | 295 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2003 | 5400 | 0.020 |
Why?
| | Prognosis | 1 | 1998 | 3830 | 0.020 |
Why?
| | Cyclic AMP | 1 | 1991 | 239 | 0.020 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 1998 | 1069 | 0.020 |
Why?
| | Antitubercular Agents | 1 | 1991 | 197 | 0.020 |
Why?
| | Complement C5 | 1 | 1989 | 77 | 0.020 |
Why?
| | Radionuclide Imaging | 2 | 1999 | 126 | 0.020 |
Why?
| | Treatment Outcome | 3 | 2015 | 10341 | 0.020 |
Why?
| | Predictive Value of Tests | 2 | 2007 | 1974 | 0.020 |
Why?
| | Cattle | 1 | 1991 | 981 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1993 | 1210 | 0.020 |
Why?
| | Neutropenia | 1 | 1988 | 135 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 1991 | 1028 | 0.020 |
Why?
| | Exercise | 1 | 1998 | 1941 | 0.020 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1987 | 113 | 0.020 |
Why?
| | Hemodynamics | 2 | 1988 | 1099 | 0.020 |
Why?
| | Blood Pressure | 1 | 1993 | 1753 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 1998 | 2376 | 0.020 |
Why?
| | Animals | 5 | 1993 | 35076 | 0.020 |
Why?
| | Survival Analysis | 1 | 2007 | 1293 | 0.010 |
Why?
| | Proportional Hazards Models | 1 | 2007 | 1235 | 0.010 |
Why?
| | Tidal Volume | 1 | 2004 | 83 | 0.010 |
Why?
| | Myocardium | 1 | 1988 | 989 | 0.010 |
Why?
| | Cells, Cultured | 1 | 1991 | 4106 | 0.010 |
Why?
| | Blood Coagulation Tests | 1 | 2003 | 56 | 0.010 |
Why?
| | Factor VIII | 1 | 2003 | 59 | 0.010 |
Why?
| | Review Literature as Topic | 1 | 2002 | 66 | 0.010 |
Why?
| | Sex Factors | 1 | 2007 | 1965 | 0.010 |
Why?
| | Regression Analysis | 1 | 2004 | 991 | 0.010 |
Why?
| | Risk Factors | 2 | 2007 | 9865 | 0.010 |
Why?
| | Kidney | 1 | 1988 | 1343 | 0.010 |
Why?
| | Haplotypes | 1 | 2003 | 473 | 0.010 |
Why?
| | Genome, Human | 1 | 2003 | 394 | 0.010 |
Why?
| | Child, Preschool | 1 | 1995 | 10514 | 0.010 |
Why?
| | Age Factors | 1 | 2007 | 3153 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2003 | 643 | 0.010 |
Why?
| | False Negative Reactions | 1 | 1999 | 52 | 0.010 |
Why?
| | Iothalamate Meglumine | 1 | 1998 | 4 | 0.010 |
Why?
| | Technetium Tc 99m Aggregated Albumin | 1 | 1998 | 6 | 0.010 |
Why?
| | Iohexol | 1 | 1998 | 17 | 0.010 |
Why?
| | Angiography, Digital Subtraction | 1 | 1998 | 45 | 0.010 |
Why?
| | Critical Illness | 1 | 2004 | 761 | 0.010 |
Why?
| | Reference Standards | 1 | 1998 | 171 | 0.010 |
Why?
| | Radiopharmaceuticals | 1 | 1998 | 167 | 0.010 |
Why?
| | Angiography | 1 | 1998 | 200 | 0.010 |
Why?
| | Probability | 1 | 1998 | 314 | 0.010 |
Why?
| | Colorado | 1 | 2007 | 4471 | 0.010 |
Why?
| | Aged, 80 and over | 2 | 1999 | 7128 | 0.010 |
Why?
| | Prospective Studies | 2 | 1999 | 7131 | 0.010 |
Why?
| | DNA | 1 | 2003 | 1412 | 0.010 |
Why?
| | Adolescent | 1 | 1995 | 20374 | 0.010 |
Why?
| | Body Mass Index | 1 | 2004 | 2268 | 0.010 |
Why?
| | Contrast Media | 1 | 1998 | 392 | 0.010 |
Why?
| | Acute Disease | 1 | 1998 | 981 | 0.010 |
Why?
| | Ultrasonography | 1 | 1999 | 731 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2003 | 3369 | 0.010 |
Why?
| | Child | 1 | 1995 | 20961 | 0.010 |
Why?
| | Anticoagulants | 1 | 1999 | 627 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 1998 | 745 | 0.010 |
Why?
| | Oxygenators | 1 | 1993 | 4 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 1998 | 1854 | 0.010 |
Why?
| | Blood Vessels | 1 | 1993 | 186 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 1999 | 3069 | 0.010 |
Why?
| | Complement System Proteins | 1 | 1993 | 309 | 0.010 |
Why?
| | Quinidine | 1 | 1987 | 6 | 0.000 |
Why?
| | Procainamide | 1 | 1987 | 6 | 0.000 |
Why?
| | Thiourea | 1 | 1987 | 40 | 0.000 |
Why?
| | Lidocaine | 1 | 1987 | 43 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1987 | 366 | 0.000 |
Why?
| | Organ Size | 1 | 1987 | 450 | 0.000 |
Why?
| | Hydrogen Peroxide | 1 | 1987 | 312 | 0.000 |
Why?
| | In Vitro Techniques | 1 | 1987 | 1067 | 0.000 |
Why?
| | Retrospective Studies | 1 | 1999 | 14675 | 0.000 |
Why?
| | Rats | 1 | 1987 | 5285 | 0.000 |
Why?
|
|
Welsh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|